HIGH · 8.8

CVE-2023-31923

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged...

Vulnerability Description

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

CVSS Score

8.8

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
SupremaincBiostar 2< 2.9.1

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-31923?

CVE-2023-31923 is a vulnerability with a CVSS score of 8.8 (HIGH). Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged...

How severe is CVE-2023-31923?

CVE-2023-31923 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-31923?

Check the references section above for vendor advisories and patch information. Affected products include: Supremainc Biostar 2.